 price-to-earnings multipl go
put beat sale guidanc go higher
still look conserv underli om report ep reiter
ex-fx om flat though fx compani
show confid underli expans year high
still find groov consist perform valuat
multipl start converg peer rais pt
strong sale guidanc still look conserv sale momentum
 broad-bas even sever standout diabet standout
neuromodul came ahead expect growth structur heart
saw strong growth tavr high-teen claim share global de
doubl digit launch resolut onyx spine came flat due us declin
combin mazor post healthi overal sale growth easili
beat model guidanc year rais
easi comp hurricane-impact last year broad-bas
perform product pipelin number still look conserv express
confid upper end guidanc rang year
om still littl soft fx make optic better adj om
constant-curr basi howev om rhetor
compani still earli cost reduct initi select chose
invest confid underl om expans year reiter
though like go focu year unfold free cash flow also
strong convers guidanc still year
fx sever hedg save day strengthen usd fx guidanc
headwind increas howev compani hedg
strategi well decis move invest gain loss line pay
guidanc report om go higher despit worsen fx outlook
rais number pt still earli new found religion
deliv sustain result valuat dispar peer look
unsustain base larg cap med-tech peer multipl top-line grower
trade ep pt goe
ep good underli result
begin data present pro forma cash basi includ covidien exclud
return average equiti
pleas see analyst certif import disclosur inform inform regard statu non-u analyst page report
sustain mid-single-digit top-lin growth next
volum growth augment new product
entri new market
invest thesi base abil achiev
mid-singl digit top-lin growth maintain market
leadership sever larg market spine diabet
neuromodul
substanti expand product portfolio organ
continu return annual form
acquisit like robot
dividend buyback
achiev dd ep growth combin mix
tuck-in acquisit bake base assumpt
pt base adjust ep
sustain mid high-single-digit top-lin growth
next year
volum growth augment new product
entri new market
tct confer
pipelin regulatori mileston
adopt hybrid closed-loop insulin pump
realiz addit covidien cost synergi
adopt stand-alone cgm sensor diabet
continu return annual form
dividend buyback
success transit anima patient
large-scal accret bake bull assumpt
pt base higher adjust ep
overal top-lin growth deceler low-singl digit
next year
volum deceler off-set new product
entri new market
profil erod return diminish
annual
large-scal dilut bake bear assumpt
pt base lower adjust ep
page
pleas see import disclosur inform page report
page
pleas see import disclosur inform page report
